Cargando…

Can Statin Prevent the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Disease?

Detalles Bibliográficos
Autor principal:	Jang, Hyun Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430435/ https://www.ncbi.nlm.nih.gov/pubmed/30893984 http://dx.doi.org/10.5009/gnl19003

Ejemplares similares

Statin use and risk of colorectal cancer in patients with inflammatory bowel disease
por: Sun, Jiangwei, et al.
Publicado: (2023)

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
por: Shah, Shailja C., et al.
Publicado: (2019)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Addressing Sexual Dysfunction in Patients with Inflammatory Bowel Disease—We Can Do Better
por: Clarke, Kofi
Publicado: (2020)

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention
por: Lucafò, Marianna, et al.
Publicado: (2021)

Screening for colorectal cancer in patients with inflammatory bowel disease. Should we already perform chromoendoscopy in all our patients?
por: Huguet, Jose María, et al.
Publicado: (2018)

Colorectal cancer risk in patients with inflammatory bowel disease and Lynch syndrome
por: Aronson, Melyssa, et al.
Publicado: (2010)

Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review
por: Marabotto, Elisa, et al.
Publicado: (2022)

Inflammatory Bowel Disease
por: Sachar, David B., et al.
Publicado: (2012)

Medications and the Risk of Colorectal Cancer in Patients with Inflammatory Bowel Diseases: Use of the Landmark Method
por: Choi, Yoon Young, et al.
Publicado: (2021)

Does the road to primary prevention of inflammatory bowel disease start from childhood?
por: Kedia, Saurabh, et al.
Publicado: (2022)

Can the Prevalence of Symptoms in Patients with Inflammatory Bowel Disease be Predicted by the Analysis of Multidrug Resistance Gene 1 Polymorphisms?
por: Chiurillo, Miguel Angel
Publicado: (2013)

Statins in primary prevention: is the enthusiasm justified?
por: Chopra, Arun K., et al.
Publicado: (2020)

Disability Index as a New Outcome Measure in Patients with Inflammatory Bowel Disease
por: Choi, Hyun Ho, et al.
Publicado: (2017)

Anti-inflammatory effects of perioperative statin therapy
por: van Klei, Wilton A., et al.
Publicado: (2012)

Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?
por: Hwang, Sung Wook
Publicado: (2022)

Bowel Preparation in Inflammatory Bowel Disease—A Necessary Evil?
por: Lightner, Amy L
Publicado: (2020)

Challenges of modern day transition care in inflammatory bowel disease: From inflammatory bowel disease to biosimilars
por: Hakizimana, Ali, et al.
Publicado: (2017)

Incident Colorectal Cancer in Inflammatory Bowel Disease
por: Neri, Benedetto, et al.
Publicado: (2022)

Does Radiation Exposure from Abdominal Computed Tomography Increase Cancer Risk in Patients with Inflammatory Bowel Disease and Behçet Disease?
por: Lim, Yun Jeong
Publicado: (2014)

Extraintestinal Manifestations of Inflammatory Bowel Disease
por: Al-Quorain, Abdulaziz A.
Publicado: (2019)

Hygiene hypothesis in inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2014)

Targeting lymphatics in inflammatory bowel disease
por: D'Aiessio, Silvia, et al.
Publicado: (2015)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

The great wall of inflammatory bowel disease
por: Al Sulais, Eman, et al.
Publicado: (2022)

Inflammatory Bowel Disease: A Global Disease
por: Ghosh, Subrata, et al.
Publicado: (2013)

Statins: benefits and risks revisited
por: Balaz, Miroslav, et al.
Publicado: (2019)

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries
por: Baek, Ji Eun, et al.
Publicado: (2023)

Hoping rosuvastatin for primary prevention of cardiovascular events, are all statins similar and are we ready for statinizing the globe?
por: Kumar, Arun H. S.
Publicado: (2016)

The Mental Health State of Quiescent Inflammatory Bowel Disease Patients
por: Park, Sung Chul, et al.
Publicado: (2016)

Depressive Symptoms and Quality of Life in the Patients of Inflammatory Bowel Disease
por: Lee, Jung Won
Publicado: (2017)

Inflammatory Bowel Disease: Changing Associations to Mechanisms
por: Click, Benjamin, et al.
Publicado: (2016)

ABC of topical therapy in inflammatory bowel disease
por: Goodsall, Thomas M, et al.
Publicado: (2020)

Inflammatory Bowel Disease and the Environment: More to Come
por: El-Matary, Wael
Publicado: (2020)

Akkermansia muciniphila in inflammatory bowel disease and colorectal cancer
por: Gu, Zhen-Yang, et al.
Publicado: (2021)

The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer
por: Liang, Lifang, et al.
Publicado: (2021)

Gut microbiota, inflammatory bowel disease and colorectal cancer
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2022)

Risk of colorectal cancer in patients with diverticular disease
por: Meyer, Jeremy, et al.
Publicado: (2018)

Statins in Variant Angina
por: Kim, Jang-Young
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bohq3u211247l5licdj4uei4n5